Is FBLG research on Rallies investment advice?

No. Rallies provides research, data, and educational context for FBLG. It does not provide personalized investment advice.

FBLG (FibroBiologics, Inc. Common Stock) Stock Analysis - Financials

FibroBiologics, Inc. Common Stock (FBLG) is a publicly traded Healthcare sector company. As of July 7, 2026, FBLG trades at $0.85 with a market cap of $4.56M and a P/E ratio of -2.06. FBLG moved +0.00% today. Year to date, FBLG is -82.04%; over the trailing twelve months it is -92.90%. Its 52-week range spans $0.73 to $71.20. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces FBLG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are FBLG's key financials?

FBLG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. FBLG recently traded at $0.85. Market cap is $4.56M. P/E ratio is -2.06. Revenue is $0.

FBLG Key Metrics

Key financial metrics for FBLG
Metric	Value
Price	$0.85
Market Cap	$4.56M
P/E Ratio	-2.06
EPS	$-0.42
Dividend Yield	0.00%
52-Week High	$71.20
52-Week Low	$0.73
Volume	18.79K
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-18.65M
Gross Margin	0.00%

FBLG Analyst Consensus

2 analysts cover FBLG: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.

Common questions about FBLG

What are FBLG's key financials?: FBLG financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. FBLG recently traded at $0.85. Market cap is $4.56M. P/E ratio is -2.06. Revenue is $0.
Is FBLG research on Rallies investment advice?: No. Rallies provides research, data, and educational context for FBLG. It does not provide personalized investment advice.